The COVID-19 pandemic has increased usage of medication delivery service (MDS) significantly. MDS improves adherence to medication and clinical outcomes.
Objectives
To study behavioral change factors that affect adoption of MDS, determine existing patient satisfaction level, and make recommendations to improve MDS adoption.
Methods
A single-institution, cross-sectional survey was conducted at the outpatient pharmacy of the largest ambulatory cancer centre in Singapore. The survey consisted of sections on demographics, Theory of Planned Behavior constructs and patient satisfaction questions. Descriptive analysis and logistic regression were used.
Results
A total of 881 patients responded. Respondents were mostly Chinese, female and subsidized patients, with a mean age of 62.4 years old. MDS use is strongly predicted by favourable attitude (OR 3.54, 95%CI 2.64–4.75; p < 0.001) and subjective norm (OR 3.07, 95%CI 2.30–4.09; p < 0.001) towards its use and greater perceived behavioral control (OR 2.48; 95%CI 1.86–3.30; p < 0.001). Being ill or frail has been identified as facilitators, while absence of face-to-face consultation and cost of delivery were barriers to the adoption of MDS. Encouragingly, the satisfaction level of our existing patients was generally high (80.2, SD16.7). Recommendation to improve MDS adoption targets facilitators and barriers identified and aims to further elevate patient satisfaction level. Establishment of a centralised pharmacy for MDS together with a call centre would be essential in the long run.
Conclusions
MDS is becoming increasingly important, in line with our national strategy. Implementation of suggested short-term and long-term measures will encourage its use.
MerksPJakubowskaMDrelichE, et al.The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Social Adm Pharm: RSAP2021; 17: 1807–1812.
2.
ChanAAshburyFFitchMI,et al.Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group. Support Care Cancer2020; 28: 3485–3488.
3.
Peláez BejaranoAVillar SantosPRobustillo-CortésMLA,et al.Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm: Sci Pract2020 doi:10.1136/ejhpharm-2020-002500.
4.
Al-ZaidanMMohamed IbrahimMIAl-KuwariMG,et al.Qatar’s primary health care medication home delivery service: a response toward COVID-19. J Multidiscip Healthc2021; 14: 651–657.
HorganCGoodyBKnappD,et al.The role of mail service pharmacies. Health Aff (Project Hope)1990; 9: 66–74.
7.
AitkenMKleinrockM. Medicine use and spending in the U.S. a review of 2018 and outlook to 2023. IQVIA Institute for Human Data Science, Parsippany, NJ, USA, 2019.
DuruOKSchmittdielJADyerWT, et al.Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care2010; 16: 33–40.
10.
NeilWPShiokariCEBurchetteRJ,et al.Mail order pharmacy use and adherence to secondary prevention drugs among stroke patients. J Neurol Sci2018; 390: 117–120.
11.
SchwabPRacsaPRascatiK,et al.A retrospective database study comparing diabetes-related medication adherence and health outcomes for mail-order versus community pharmacy. J Manag Care Spec Pharm2019; 25: 332–340.
12.
SchmittdielJAKarterAJDyerWT,et al.Safety and effectiveness of mail order pharmacy use in diabetes. Am J Manag Care2013; 19: 882–887.
13.
DevineSVlahiotisASundarH. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ2010; 13: 203–211.
14.
VidallC. Providing community oral chemotherapy services. Eur J Cancer Care2010; 19: 29–34.
15.
LohBCWahKFTeoCA,et al.Impact of value added services on patient waiting time at the ambulatory pharmacy Queen Elizabeth Hospital. Pharm Pract2017; 15: 846.
16.
SteckowychKSmithMSpiggleS,et al.Building the case: changing consumer perceptions of the value of expanded community pharmacist services. J Pharm Pract2019; 32: 637–647.
17.
RuppMT. Attitudes of medicare-eligible Americans toward mail service pharmacy. J Manag Care Pharm: JMCP2013; 19: 564–572.
18.
SchmittdielJAMarshallCJWileyD, et al.Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. BMC Health Serv Res2019; 19: 422.
19.
TanCLHassaliMASaleemF,et al.Building intentions with the theory of planned behaviour: a qualitative assessment of salient beliefs about pharmacy value added services in Malaysia. Health Expectations: Int J Public Participation Health Care Health Policy2016; 19: 1215–1225.
20.
Abdul-MuhminAG. Repeat purchase intentions in online shopping: the role of satisfaction, attitude, and online Retailers’ performance. J Int Consum Mark2010; 23: 5–20.
21.
FornellC. A national customer satisfaction barometer: the Swedish experience. J Mark1992; 56: 6–21.
22.
Agency for Healthcare Research and Quality. Section 2: Why Improve Patient Experience? The CAHPS Ambulatory Care Improvement Guide, 2017.
23.
DoyleCLennoxLBellD. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open2013; 3: e001570.
24.
AjzenI. From intentions to actions: a theory of planned behavior. In: KuhlJBeckmannJ (eds) Action control. Berlin, Heidelberg: Springer, SSSP Springer Series in Social Psychology, 1985, pp.11–39.
25.
GavazaPBrownCMLawsonKA,et al.Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm: RSAP2011; 7: 369–382.
26.
HasanSAMuzumdarJMNayakR,et al.Using the theory of planned behavior to understand factors influencing south Asian consumers’ intention to seek pharmacist-provided medication therapy management services. Pharmacy (Basel, Switzerland)2019; 7: 88.
27.
AjzenI. The theory of planned behavior. Organ Behav Hum Decis Process1991; 50: 179–211. 1991/12/01/.
28.
FrancisJEcclesMPJohnstonM, et al.Constructing questionnaires based on the theory of planned behaviour: a manual for health services researchers. Newcastle upon Tyne, UK: University of Newcastle upon Tyne, 2004.
29.
TanCLHassaliMASaleemF,et al.Development, test-retest reliability and validity of the pharmacy value-added services questionnaire (PVASQ). Pharm Pract2015; 13: 598.
30.
LarsonLNMacKeiganLD. Further validation of an instrument to measure patient satisfaction with pharmacy services. J Pharmaceut Marketing Manage1994; 8: 125–139. 1994/01/01.
31.
MacKeiganLDLarsonLN. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care1989; 27: 522–536.
32.
JohnsonJACoonsSJHaysRD,et al.A comparison of satisfaction with mail versus traditional pharmacy services. J Manag Care Pharm1997; 3: 327–337.
33.
LawsheCH. A quantitative approach to content validity. Pers Psychol1975; 28: 563–575.
34.
National Registry of Disease Office. Singapore Cancer Registry 50th Anniversary Monograph (1968–2017), 2019.
35.
LibermanJNWangYHutchinsDS,et al.Revealed preference for community and mail service pharmacy. J Am Pharm Assoc: JAPhA2011; 51: 50–57.
36.
RashrashMETomaszewskiDMSchommerJC,et al.Consumers’ characteristics associated with the use of mail pharmacy services in the United States: findings from the 2015 national consumer survey on the medication experience. J Am Pharm Assoc: JAPhA2017; 57: 206–210.
37.
LauBTNurul-Nadiah-AuniARNgSY,et al.Satisfaction of patients receiving value added-services compared to traditional counter service for prescription refills in Malaysia. Pharm Pract2018; 16: 1075.
38.
WuJDavis-AjamiMLNoxonV. Patterns of use and expenses associated with mail-service pharmacy in adults with diabetes. J Am Pharm Assoc: JAPhA2015; 55: 41–51.
39.
ChanH-KShahabudinNAGhaniNA,et al.Satisfaction with traditional counter versus value-added services for prescription claims in a Malaysian tertiary hospital. J Pharm Health Serv Res2015; 6: 61–68.
40.
UNESCO Institute of Statistics. Data for the Sustainable Development Goals: Education and Literacy, http://uis.unesco.org/en/country/sg (accessed 28 February 2021).
41.
LiASWFiggGSchüzB. Socioeconomic status and the prediction of health promoting dietary behaviours: a systematic review and meta-analysis based on the theory of planned behaviour. Appl Psychol Health Well-being2019; 11: 382–406.
42.
SchüzBLiAS-WHardingeA,et al.Socioeconomic status as a moderator between social cognitions and physical activity: systematic review and meta-analysis based on the theory of planned behavior. Psychol Sport Exerc2017; 30: 186–195. 2017/05/01/.
43.
ShelbyRATaylorKLKernerJF,et al.The role of community-based and philanthropic organizations in meeting cancer patient and caregiver needs. CA Cancer J Clin2002; 52: 229–246.
IlardoMLSpecialeA. The community pharmacist: perceived barriers and patient-centered care communication. Int J Environ Res Public Health2020; 17: 536.
46.
TatesKAntheunisMLKantersS,et al.The effect of screen-to-screen versus face-to-face consultation on doctor-patient communication: an experimental study with simulated patients. J Med Int Res2017; 19: e421.
BirtcherKKShepherdMD. Users’ perceptions of mail-service pharmacy. Am Pharm1992; Ns32: 35–41.
49.
SchwappachDLWernliM. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care2010; 19: 285–292.
50.
ChuaGPTanHKGandhiM. Information sources and online information seeking behaviours of cancer patients in Singapore. Ecancermedicalscience2018; 12: 880–880.
51.
GovenderNSulemanF. Comparison of patient satisfaction with pharmaceutical services of postal pharmacy and community pharmacy. Health SA=SA Gesondheid2019; 24: 1105.
52.
ChenQBealEWOkunrintemiV, et al.The association between patient satisfaction and patient-reported health outcomes. J Patient Exp2019; 6: 201–209.
53.
NaughtonMJWeaverKE. Physical and mental health among cancer survivors: considerations for long-term care and quality of life. N C Med J2014; 75: 283–286.
54.
WangYDuanZMaZ, et al.Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Transl Psychiatry2020; 10: 263.
GrimeJBlenkinsoppARaynorDK,et al.The role and value of written information for patients about individual medicines: a systematic review. Health Expectations: Int J Public Participation Health Care and Health Policy2007; 10: 286–298.
58.
KooMKrassIAslaniP. Consumer opinions on medicines information and factors affecting its use—an Australian experience. Int J Pharm Pract2002; 10: 107–114.
59.
Brar PrayagaRJeongEWFegerE,et al.Improving refill adherence in medicare patients with tailored and interactive mobile text messaging: pilot study. JMIR Mhealth Uhealth2018; 6: e30.
60.
KappenmanAMRagsdaleRRimMH,et al.Implementation of a centralized mail-order pharmacy service. Am J Health-system Pharm: AJHP: Official J Am Soc Health-System Pharm2019; 76(Supplement_3): S74–S78.
61.
AragonBRPierce IiRAJonesWN. VA CMOPs: producing a pattern of quality and efficiency in government. J Am Pharm Assoc2012; 52: 810–815. 2012/11/01/.
62.
AgatzNCampbellAFleischmannM,et al.Time slot management in attended home delivery. Transp Sci2011; 45: 435–449.
63.
VinsensiusAWangYChewEK,et al.Dynamic incentive mechanism for delivery slot management in E-commerce attended home delivery. 2020; 54: 567–587.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
